Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dermatology Diagnostic Devices And Therapeutics Market 

5.1. COVID-19 Landscape: Dermatology Diagnostic Devices And Therapeutics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dermatology Diagnostic Devices And Therapeutics Market, By Diagnostic Devices

8.1. Dermatology Diagnostic Devices And Therapeutics Market, by Diagnostic Devices, 2023-2032

8.1.1 Dermatoscopes

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Microscopes and Trichoscopes

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Imaging Equipment

8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Dermatology Diagnostic Devices And Therapeutics Market, By Application Class

9.1. Dermatology Diagnostic Devices And Therapeutics Market, by Application Class, 2023-2032

9.1.1. Diagnostic Devices

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Treatment Devices

Chapter 10. Global Dermatology Diagnostic Devices And Therapeutics Market, By End Use 

10.1. Dermatology Diagnostic Devices And Therapeutics Market, by End Use, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Clinics

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Others

Chapter 11. Global Dermatology Diagnostic Devices And Therapeutics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.1.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.1.3. Market Revenue and Forecast, by End Use (2021-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.1.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.1.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.6.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.2.7.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.6.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.3.7.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.6.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.4.7.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.5.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.5.4.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Diagnostic Devices (2021-2032)

11.5.5.2. Market Revenue and Forecast, by Application Class (2021-2032)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2032)

Chapter 12. Company Profiles

12.1. Canfield Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Novartis International AG

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Valeant Pharmaceuticals International, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. gfa-Gevaert N.V.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Galderma S.A.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Michelson Diagnostics Ltd.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cutera, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Astellas Pharma, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Genentech

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. GlaxoSmithKline plc

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms